This session will cover identifying, assessing, and reporting adverse events (AEs) for medical device studies at the site level. An overview of the possible sources for potential events will be provided along with best practices for establishing a process of assessing events and a workflow for reporting events to sponsors and IRBs. Common hurdles that sites face and possible solutions will be provided. This course will explain how to apply 21CFR812, ICH-GCP E6, ISO 14155, protocol requirements and IRB policies. Actual questions from FDA investigators during site audits will be included.
Upon completion of this Webinar, attendees should be able to:
Understand the different methods and possible sources for identifying adverse events.
Understand the reporting requirements and recommended procedures for AE reports to sponsors and IRBs.
We are using cookies to give you the best experience on our website.
You can find out more about which cookies we are using or switch them off in settings.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.